Letter to the editor

Journal of Dermatology

Volumn 26, Issue 12, 1999, Pages 837-840

  Shimizu, Takahiro ^a   Murakami, Tomoyuki ^b   Oga, Atsunori ^a   Furumoto, Hiroko ^a   Nakano, Junji ^c   Muto, Masahiko ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL SANYO HOSPITAL   (Japan)

^c Tokuyama Central Hospital   (Japan)

Author keywords

Ki 67 antigen; metastasis; p53 protein; squamous cell carcinoma

Indexed keywords

GENE PRODUCT; KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PHOSPHOPROTEIN; PROTEIN P53;

CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHROMOSOME 17; CLINICAL ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; METASTASIS; PROGNOSIS; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROGNOSIS; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033370957     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb02104.x     Document Type: Letter

References (12)

1. Shimizu T, Murakami T, Oga A, Muto M,: Overexpression of p53 protein associated with proliferative activity and histological degree of malignancy in solar keratosis, Dermatology (in press)
2. Shimizu T, Muto M, Murakami T, Furumoto H, Mogami S, Asagami C,: Overexpression of p53 protein associated with proliferative activity as evaluated by Ki-67 immunostaining in well-differentiated squamous cell carcinoma of the skin, Dermatology, 195: 224-227, 1997.
3. Lane DP, Benchimol S,: p53: Oncogene or antioncogene, Genes Devel, 4: 1-8, 1990.
4. Levine AJ, Momand J, Finlay CA,: The p53 tumor suppressor gene, Nature, 351: 453-456, 1991.
5. Fields S, Jang SK,: Presence of a potent transcription activating sequence in the p53 protein, Science, 249: 1046-1048, 1990.
6. Lane DP,: p53, guardian of the genome, Nature, 358: 15-16, 1992.
7. Mansoor A, McKee PH, Simpson JA, McGuire B, Hobbs C,: Prognostic significance of Ki-67 and p53 immunoreactivity in cutaneous squamous cell carcinomas, Am J Dermatopathol, 18: 351-357, 1996.
8. Resnick JM, Cherwitz D, Knapp D, Uhlman D, Niehans GA,: A microwave method that enhances detection of aberrant p53 expression in formalin-fixed, paraffin-embedded tissues, Arch Pathol Labo Med, 119: 360-366, 1995.
9. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H,: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J Immunol, 133: 1710-1715, 1984.
10. Brown DC, Gatter KG,: Monoclonal antibody Ki-67; Its use in histopathology, Histopathology, 17: 489-503, 1990.
11. Ueda T, Aozasa K, Tsujimoto M, et al. Prognostic significance of Ki-67 reactivity in soft tissure sarcomas, Cancer, 63: 1607-1611, 1989.
12. Wintzer H-O, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S,: Ki-67 immunostaining in human breast tumors and its relationship to prognosis, Cancer, 67: 421-428, 1991.